(6R,7R)-7-[[(2Z)-2-(2-amino-1,
3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[[5-(carboxymethyl)-4-
methyl-1,
3-thiazol-2-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-
ene-2-carboxylic acid

Produktsname:	(6R,7R)-7-[[(2Z)-2-(2-amino-1, 3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[[5-(carboxymethyl)-4- methyl-1, 3-thiazol-2-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2- ene-2-carboxylic acid
CAS Registry Number:	69739-16-8
Synonyme:	HR-221;(6R,7R)-7-[[(2Z)-2-(2-amino-1, 3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[[5-(carboxymethyl)-4- methyl-1, 3-thiazol-2-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2- ene-2-carboxylic acid; Diezime; Cefodizimum; Timecef; Modivid; CDZM; Cefodizme; 69739-16-8;Cefodizima;
Molecular Structure:
Molecular Formula:	C₂₀H₂₀N₆O₇S₄
Molecular Weight:	584.6688
Dichte:	1.86 g/cm³
Brechungsindex:	1.851
Risiko-Codes:	36/37/38-42/43
S-Sätze:	S22;S26;S36/37/39;
Gefahrensymbole:	Xi

(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[[5-(carboxymethyl)-4-methyl-1,3-thiazol-2-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid